Patent · US Active

Heterocyclic compounds and uses thereof

US9085560B2 · kind B2 · utility

33Cited by
4References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 17, 2010
Grant dateJul 21, 2015
Priority date
Expiry dateMay 2, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of inhibiting phosphatidyl inositol-3 kinase (PI3 kinase), comprising: contacting the PI3 kinase with an effective amount of a compound or pharmaceutically acceptable salt of the formula below,wherein the variables R1, R2, W1, W2, W3, W4, W5, are W6 are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.